Acadia Healthcare Reports Flat Revenue Amid Rising Costs and Liability Adjustments — Acadia Healthcare Company, Inc.

Event summary

Acadia Healthcare reported $865.8 million in revenue for Q2 2026, flat compared to the same period in 2025.
Net income attributable to Acadia dropped 64% year-over-year to $10.9 million.
Adjusted EBITDA declined 26% due to a $28.6 million adjustment to professional and general liability reserves.
The company added 240 licensed beds during the quarter from newly constructed facilities.
Acadia updated its full-year 2026 financial guidance, narrowing revenue expectations to $3.40–$3.45 billion.

The big picture

Acadia Healthcare's Q2 results reflect the challenges of balancing expansion with cost control in a sector facing regulatory shifts. The company's flat revenue and declining profitability highlight the pressure from liability adjustments and supplemental payment program timing, while its updated guidance suggests cautious optimism for the remainder of 2026. As the largest stand-alone behavioral healthcare provider in the U.S., Acadia's ability to navigate these dynamics will be critical for maintaining its market position.

What we're watching

Cost Management: How Acadia will address rising operating expenses, particularly professional and general liability costs.
Regulatory Impact: Whether changes in Medicaid financing mechanisms under the One Big Beautiful Bill Act will affect patient volumes and revenue.
Expansion Strategy: The pace at which Acadia can integrate new facilities and sustain occupancy rates amid competitive pressures.